title: C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunity.
abstract: Adenovirus genes required for the elicitation of adenovirus group C-specific cytolytic T lymphocytes (CTLs) and for the induction of adenovirus-specific transplantation antigen (TSTA) were identified by immunization with a library of adenovirus mutants. The group C Ad-specific CTL response was elicited by immunization with wild-type adenovirus type 5 (Ad5) or with recombinant adenoviruses containing Ad5 E1A gene. The specific CTL response was also elicited by Ad5 virus constructs which express only the 12 S or 13 S E1A early mRNA, but not with viruses unable to express E1A protein sequences normally encoded by the E1A early messages. The induction of transplantation immunity against tumorigenic Ad-transformed cells was studied next. The product encoded by either 13 S and 12 S E1A mRNA alone was sufficient for strong TSTA activity. A series of viruses with mutations within the first exon of the E1A message also induced strong TSTA, while Ad5 mutants with lesions within the second exon failed to induce syngraft immunity. These results provide strong evidence that amino acid sequence encoded by the second exon of the Ad5 E1A message is required, either directly or indirectly, for the induction of both Ad-specific CTL and Ad TSTA.
authors.affiliation: Department of Pathology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854.
authors.forename: D
authors.initials: D
authors.lastname: Urbanelli
authors.forename: Y
authors.initials: Y
authors.lastname: Sawada
authors.forename: J
authors.initials: J
authors.lastname: Raskova
authors.forename: N C
authors.initials: NC
authors.lastname: Jones
authors.forename: T
authors.initials: T
authors.lastname: Shenk
authors.forename: K
authors.initials: K
authors.lastname: Raska
mesh_terms: D017456:Adenovirus Early Proteins; D000260:Adenoviruses, Human / Q000235:genetics* / Q000276:immunology; D000595:Amino Acid Sequence; D000818:Animals; D000951:Antigens, Neoplasm / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D000957:Antigens, Viral, Tumor / Q000235:genetics; D002461:Cell Line, Transformed; D005091:Exons; D006649:Histocompatibility Antigens / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000235:genetics*; D011233:Precipitin Tests; D012333:RNA, Messenger / Q000235:genetics; D012367:RNA, Viral / Q000235:genetics; D051381:Rats; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014181:Transplantation Immunology; D014771:Virion / Q000235:genetics / Q000276:immunology
chemical_list: D017456:Adenovirus Early Proteins; D000951:Antigens, Neoplasm; D000957:Antigens, Viral, Tumor; D006649:Histocompatibility Antigens; D009856:Oncogene Proteins, Viral; D012333:RNA, Messenger; D012367:RNA, Viral; C029237:tumor-associated transplantation antigen